FinlandFinland

Biotie axes acquisition of Newron

31.10.2011

Bresso/Turku – The wedding's off between Newron and Biotie. The bride has run away. Shares in Italy's Newron Pharmaceuticals plunged after its proposed merger with Biotie Therapies Corp was called off by the Finnish firm. Biotie’s decision to terminate the merger plan, which was made public in September, follows Newron’s announcement a week ago that Merck Serono, its global partner for the Phase III Parkinson disease therapy safinamide, would pass the drug back to Newron in April 2012. Merck believes "safinamide has a more limited market potential than originally anticipated".
Biotie says that under terms of the merger plan and combination agreement the return of safinamide rights to Newron constitutes a material adverse effect and gives it the right to cancel the deal. As a result, the Turku-based firm will also receive a break-up fee of 1.5 million euros from Newron.
Newron is putting up a brave face maintaining that that regaining global commercial rights to safinamide will open up “substantial opportunities to create value for its shareholders.” Newron believes a registration dossier will be ready for submission to health authorities by the end of 2012, pending results from the Phase III Motion and Settle studies, which are scheduled to report during the first half of next year. It has hired consultants JSB Partners to help study the alternatives. The divorce is "the opportunity to pursue all strategic options", said Chief executive Luca Benatti.

FinlandFinland

19.09.2009

Helsinki – According to a new survey, Finnish high-tech growth companies raised almost a51m in the first half of 2009, 17% down on the first half of 2008. Second quarter funding decreased by more than 50% from the same period in...

FinlandFinland

13.07.2009

Helsinki – The Finnish government has announced plans to introduce tax incentives for companies with high research and development activities. At the end of June, a working group from the Ministry of Employment and Economy (MEE)...

FinlandFinland

05.06.2009

Espoo – Finnish pharmaceutical and dia­gnostics company OrionA/S has agreed to pay Abbott US$18m to re-acquire the rights to the intravenous formulation of its heart failure treatment levosimendan, which is marketed as...

FinlandFinland

29.04.2009

Helsinki – The Finnish Funding Agency for Technology and Innovation (Tekes), and the forest-based industry organised in the Finnish Forest Cluster have announced the five-year-research programme “Future Refinery” (FuBio), a...

FinlandFinland

21.02.2009

Helsinki – The Finnish Government has set up a new innovation policy. As its starting point, the Science and Technology Policy Council adopted the report “Review2008” in December, which outlines Finland’s new national strategy...

FinlandFinland

07.10.2008

A Helsinki – The causes of human anxiety disorders are largely unexplored, so there are currently no targeted drugs available for treatment. That’s why Finnish researchers from the Academy of Finland Research Programme on...

FinlandFinland

14.08.2008

Helsinki – A proposal for national innovation strategy has laid down new outlines for reforming Finland’s innovation policy, and has presented an action programme for their implementation. The proposal was submitted on June 12th...

FinlandFinland

20.05.2008

Helsinki – The Technology Academy Finland, an independent foundation established by Finnish industry, has announced the 4 finalists for the 2008 Millenium Technology Prize, which is awarded for technological innovation that...

FinlandFinland

19.03.2008

Helsinki – A study conducted by the research arm of the global assurance firm Allianz SE for the Lisbon Council, a Brussels-based think tank, has concluded that Finland already fulfills all of the criteria for the so-called...

FinlandFinland

19.03.2008

Helsinki – An international research team under Prof. Rasmus Nielsen from Copenhagen University has discovered that Europeans carry significantly more deleterious mutations in their genomes than Africans. The results are based on...

Displaying results 21 to 30 out of 96

< Previous 21-30 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-finland/browse/2/article/biotie-axes-acquisition-of-newron.html

Product of the week

Products

Events

All Events

Current issue

All issues